CNBC just announced: “Pfizer CEO says it will be able to deliver Seagen’s cancer therapy at a scale not seen before with $43 billion deal” (click here)
Seagen is a “leading developer” of medicine called antibody-drug conjugates, or ADCs, which are designed to kill cancer cells and spare healthy ones. ADCs use antibodies to deliver small molecule drugs di…
Watch with a 7-day free trial
Subscribe to COVID Intel - by Dr.William Makis to watch this video and get 7 days of free access to the full post archives.
